AIM: To create a new, automated method of evaluating the quality of optical coherence tomography (OCT) images and to compare its image quality discriminating ability with the quality assessment parameters signal to noise ratio (SNR) and signal strength (SS). METHODS: A new OCT image quality assessment parameter, quality index (QI), was created. OCT images (linear macular scan, peripapillary circular scan, and optic nerve head scan) were analysed using the latest StratusOCT system. SNR and SS were collected for each image. QI was calculated based on image histogram information using a software program of our own design. To evaluate the performance of these parameters, the results were compared with subjective three level grading (excellent, acceptable, and poor) performed by three OCT experts. RESULTS: 63 images of 21 subjects (seven each for normal, early/moderate, and advanced glaucoma) were enrolled in this study. Subjects were selected in a consecutive and retrospective fashion from our OCT imaging database. There were significant differences in SNR, SS, and QI between excellent and poor images (p = 0.04, p = 0.002, and p<0.001, respectively, Wilcoxon test) and between acceptable and poor images (p = 0.02, p<0.001, and p<0.001, respectively). Only QI showed significant difference between excellent and acceptable images (p = 0.001). Areas under the receiver operating characteristics (ROC) curve for discrimination of poor from excellent/acceptable images were 0.68 (SNR), 0.89 (IQP), and 0.99 (QI). CONCLUSION: A quality index such as QI may permit automated objective and quantitative assessment of OCT image quality that performs similarly to an expert human observer.
AIM: To create a new, automated method of evaluating the quality of optical coherence tomography (OCT) images and to compare its image quality discriminating ability with the quality assessment parameters signal to noise ratio (SNR) and signal strength (SS). METHODS: A new OCT image quality assessment parameter, quality index (QI), was created. OCT images (linear macular scan, peripapillary circular scan, and optic nerve head scan) were analysed using the latest StratusOCT system. SNR and SS were collected for each image. QI was calculated based on image histogram information using a software program of our own design. To evaluate the performance of these parameters, the results were compared with subjective three level grading (excellent, acceptable, and poor) performed by three OCT experts. RESULTS: 63 images of 21 subjects (seven each for normal, early/moderate, and advanced glaucoma) were enrolled in this study. Subjects were selected in a consecutive and retrospective fashion from our OCT imaging database. There were significant differences in SNR, SS, and QI between excellent and poor images (p = 0.04, p = 0.002, and p<0.001, respectively, Wilcoxon test) and between acceptable and poor images (p = 0.02, p<0.001, and p<0.001, respectively). Only QI showed significant difference between excellent and acceptable images (p = 0.001). Areas under the receiver operating characteristics (ROC) curve for discrimination of poor from excellent/acceptable images were 0.68 (SNR), 0.89 (IQP), and 0.99 (QI). CONCLUSION: A quality index such as QI may permit automated objective and quantitative assessment of OCT image quality that performs similarly to an expert human observer.
Authors: Wolfgang Drexler; Harald Sattmann; Boris Hermann; Tony H Ko; Michael Stur; Angelika Unterhuber; Christoph Scholda; Oliver Findl; Matthias Wirtitsch; James G Fujimoto; Adolf F Fercher Journal: Arch Ophthalmol Date: 2003-05
Authors: Lelia A Paunescu; Joel S Schuman; Lori Lyn Price; Paul C Stark; Siobahn Beaton; Hiroshi Ishikawa; Gadi Wollstein; James G Fujimoto Journal: Invest Ophthalmol Vis Sci Date: 2004-06 Impact factor: 4.799
Authors: D Huang; E A Swanson; C P Lin; J S Schuman; W G Stinson; W Chang; M R Hee; T Flotte; K Gregory; C A Puliafito Journal: Science Date: 1991-11-22 Impact factor: 47.728
Authors: J S Schuman; M R Hee; A V Arya; T Pedut-Kloizman; C A Puliafito; J G Fujimoto; E A Swanson Journal: Curr Opin Ophthalmol Date: 1995-04 Impact factor: 3.761
Authors: J G Fujimoto; M E Brezinski; G J Tearney; S A Boppart; B Bouma; M R Hee; J F Southern; E A Swanson Journal: Nat Med Date: 1995-09 Impact factor: 53.440
Authors: M R Hee; C A Puliafito; J S Duker; E Reichel; J G Coker; J R Wilkins; J S Schuman; E A Swanson; J G Fujimoto Journal: Ophthalmology Date: 1998-02 Impact factor: 12.079
Authors: Viviane Guedes; Joel S Schuman; Ellen Hertzmark; Gadi Wollstein; Anthony Correnti; Ronald Mancini; David Lederer; Serineh Voskanian; Leonardo Velazquez; Helena M Pakter; Tamar Pedut-Kloizman; James G Fujimoto; Cynthia Mattox Journal: Ophthalmology Date: 2003-01 Impact factor: 12.079
Authors: Larry Kagemann; Gadi Wollstein; Hiroshi Ishikawa; Ian A Sigal; Lindsey S Folio; Juan Xu; Haiyan Gong; Joel S Schuman Journal: Exp Eye Res Date: 2011-04-15 Impact factor: 3.467
Authors: Yijun Huang; Sapna Gangaputra; Kristine E Lee; Ashwini R Narkar; Ronald Klein; Barbara E K Klein; Stacy M Meuer; Ronald P Danis Journal: Invest Ophthalmol Vis Sci Date: 2012-04-24 Impact factor: 4.799
Authors: Chieh-Li Chen; Hiroshi Ishikawa; Yun Ling; Gadi Wollstein; Richard A Bilonick; Juan Xu; James G Fujimoto; Ian A Sigal; Larry Kagemann; Joel S Schuman Journal: Invest Ophthalmol Vis Sci Date: 2013-11-05 Impact factor: 4.799
Authors: Robert A Avery; Avital Cnaan; Joel S Schuman; Chieh-Li Chen; Natalie C Glaug; Roger J Packer; Graham E Quinn; Hiroshi Ishikawa Journal: Am J Ophthalmol Date: 2014-07-25 Impact factor: 5.258
Authors: Robert A Avery; Avital Cnaan; Joel S Schuman; Chieh-Li Chen; Natalie C Glaug; Roger J Packer; Graham E Quinn; Hiroshi Ishikawa Journal: Am J Ophthalmol Date: 2014-06-28 Impact factor: 5.258
Authors: Andrea Lozzi; Anant Agrawal; Adam Boretsky; Cristin G Welle; Daniel X Hammer Journal: Biomed Opt Express Date: 2015-06-12 Impact factor: 3.732
Authors: Hiroshi Ishikawa; Chieh-Li Chen; Gadi Wollstein; Jonathan L Grimm; Yun Ling; Richard A Bilonick; Ian A Sigal; Larry Kagemann; Joel S Schuman Journal: Invest Ophthalmol Vis Sci Date: 2013-01-30 Impact factor: 4.799